Semperit (SEM) Austrian Select Conference summary
Event summary combining transcript, slides, and related documents.
Austrian Select Conference summary
23 Apr, 2026Key milestones and strategic direction
Aims to surpass €1 billion in sales through profitable growth, focusing on high-growth segments, innovation, and technological leadership, up from €700 million in the last financial year.
Maintains leading positions in niche elastomer markets, leveraging a resilient business model, global footprint, and high-quality applications for industrial customers.
Strategic levers include growth in high-value segments, innovation, operational excellence, and fostering a diverse, global team.
Two main business segments: Industrial Applications (hoses, profiles) and Engineered Applications (conveyor belts, silicone, handrails), both leveraging in-house rubber compounding and R&D.
Investments in expanding production capacity in Czech Republic and Austria, with full ramp-up expected by 2030.
Operational and financial performance
Demonstrated resilience during a challenging year with weak markets, customer caution, and FX headwinds, achieving strong margin recovery in H2 2025.
Operating EBITDA reached €84 million (or €83.6m), above guidance, with margin recovery up to 15.3% in Q4 and SIA division margin at 19.5%.
Cost savings of over €30 million realized over three years, with a new program targeting €10 million annual savings from 2025; €6 million saved in 2025.
Free cash flow maintained at €37 million, net debt/EBITDA at 1.2, and equity ratio at 48.5%, with disciplined CapEx management.
Business model highly sensitive to capacity utilization, with significant EBITDA swings tied to revenue changes.
Innovation and sustainability initiatives
Innovation is a key growth driver, with new products like RFID-enabled Rubbertec for digital product passports and lifecycle monitoring.
Advanced circularity projects include reclaimed EPDM profiles with reduced carbon footprint and increased recycled waste share to 55%, reducing waste per product unit by 20% compared to 2023.
Expanded LSR production in Thalheim and Miami, focusing on healthcare and premium quality standards.
Megatrends such as urbanization, demographic shifts, mobility, climate adaptation, and electrification support long-term demand.
ESG targets for 2030 include reductions in energy, emissions, and waste, with strong progress in diversity and compliance.
Latest events from Semperit
- Operating EBITDA beat guidance and margin rebounded; 2026 targets growth and higher profitability.SEM
Q4 202518 Mar 2026 - EBITDA up 7.9% to €47.3m, medical business divested, and cost savings exceeded targets.SEM
Q2 20241 Feb 2026 - EBITDA up 11.9% to EUR 63.9m, profit positive, and 2024 guidance reaffirmed.SEM
Q3 202416 Jan 2026 - EBITDA up 21%, earnings positive, and free cash flow nearly doubled despite weak demand.SEM
Q4 202424 Dec 2025 - Q3 2025 profit turnaround and strong order intake support a confident full-year EBITDA outlook.SEM
Q3 202517 Dec 2025 - Q1 2025 saw steep profit declines, improved cash flow, and cautious optimism for H2 recovery.SEM
Q1 202526 Nov 2025 - Q2 recovery lifted order intake and margins; full-year EBITDA guidance and CapEx confirmed.SEM
Q2 202523 Nov 2025